mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced  
Phone 01494 818 000
Current Jobs

HCP Representative
Location: London

Territory Manager - Sports Medicine
Location: Devon and Cornwall

Urology Sales Specialist
Location: West Midlands

Senior Brand Manager (Maternity Cover)
Location: Cambridge

Sales Specialist
Location: London

Global Planning Partner
Location: London

Skin Health Sales Representative
Location: Peterborough, Cambs, Northants

Territory Manager - Sports Medicine
Location: Western Ireland

Senior Business Unit Manager
Location: Berkshire

Senior Account Executive
Location: Kent

HCP Representative
Location: Scotland

Nurse Advisor
Location: Scottish Highlands

Nurse Advisor
Location: Forth Valley

Sales Specialist - PAS
Location: South East

Account Executive - AHS
Location: Midlands C04

Schering-Plough announces changes to corporate governance

Posted on 19/12/2006 in Pharmaceutical Company Restructures

Schering-Plough's board of directors has announced four actions aimed at improving corporate governance at the company.

These actions include the termination of its existing shareholders' rights plan and a proposal to reduce supermajority shareholder voting requirements for decisions such as removing a director.

Other actions announced were a proposal to have directors elected by majority of shareholders, rather than a plurality and speeding up other previously approved changes for election.

The company commented that it appreciated the contributions from its shareholders in addition to input to CalPers, the Sheet Metal Workers National Pension Fund and others in the development of its framework of corporate governance.

Fred Hassan, chairman of the board and chief executive officer of the company, said: "We believe it is important to stay in tune with the expectations of our shareholders and our evolving environment."

He added that as the company aims to progress into a high-performance firm, it would plan to take the measures required for robust corporate governance.

The board of directors of Schering-Plough recently declared a quarterly dividend of 5.5 cents (2.8p) for each common share, to be paid on February 27th next year to those with recorded shares as of February 2nd 2007.

Other news stories from 19/12/2006

Read more in the Zenopa News Archive

How this news is generated

Mark
Managing Director
01494 818 049
(Mon to Fri 0830 to 1800 hours)
md@zenopa.com

Pharmaceutical Sales Jobs | Pharmaceutical Executive Jobs | Pharmaceutical Marketing Jobs | Medical Sales Jobs | Medical Devices Marketing Jobs | Medical Executive Jobs
Dental Sales Jobs | Veterinary Sales Jobs | Scientific Sales Jobs | Consumer Healthcare Sales Jobs | Consumer Healthcare Management Jobs | Medical Writing Jobs
Medical Writer Jobs | Healthcare PR Jobs | Animal Health Sales Jobs

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2012 Zenopa Ltd | terms & conditions of use